Medicament composition for preventing prostatic diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and prostate technology, applied in the field of medicine, can solve problems such as undiscovered, and achieve the effects of short production cycle, broad application prospects and low cost
Inactive Publication Date: 2012-07-18
JILIN ACAD OF TRADITIONAL CHINESE MEDICINE
View PDF6 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] Before the completion of the present invention, no report was found on the composition consisting of glucoside, syringin and cubicin extracted from glucoside as a drug for preventing and tr
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0073] Example 1, (preparation of composition)
[0074] Grind 2kg of the medicinal material of Jiubing into a coarse powder, reflux extraction with 70% ethanol of 8 times the weight of the medicinal material for 3 times, each time for 2 hours, filter, combine the filtrate, recover the ethanol to 2500ml, filter, and take the filter cake Extract I was obtained; the filtrate was evaporated until there was no alcohol smell, passed through the treated D101 or AB-8 macroporous resin column, washed with water until it was colorless, and then eluted 4BV with 50% ethanol, collected the ethanol eluate, and recovered Concentrate with ethanol to obtain extract II; combine extract I and extract II, and dry to obtain 155.3 g of JJBing pharmaceutical composition. Using high performance liquid chromatography to measure and calculate, syringin accounted for 21.3%, catechin glycoside accounted for 55.6%, and betamic acid accounted for 3.8%.
Embodiment 2
[0075] Embodiment 2, (capsule)
[0076] Composition raw materials 200g, appropriate amount of medicinal starch, mixed evenly, granulated, dried, granulated, filled into No. 1 capsules, made into 1000 capsules, ready to go. 2 capsules each time, 2 times a day.
Embodiment 3
[0077] Embodiment 3, (tablet)
[0078] Composition raw material 200g, appropriate amount of medicinal starch, appropriate amount of dextrin, mix uniformly, granulate, dry, granulate, dry, add appropriate amount of lubricant, compress into tablets, make 1000 tablets, and get ready. 2 tablets each time, 2 times a day.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses an ilicis rotundae cortex medicament composition for preventing such diseases as prostatitis and prostatic hyperplasia. The composition is obtained through extraction from barks of llex rotunda thunb. and refinement and is characterized by being formed by pedunculoside, syringin, rotundic acid and other substances. Pharmacological tests prove that the composition has the effect of preventing prostatitis, prostatic hyperplasia and the like. The composition has new application to preparing medicaments for preventing prostatic diseases. Pharmaceutic preparations of the composition are elaborated and can be any one of tablets, capsules, pills, granules, suspensions, dripping pills, ointments and rectal administration preparations such as suppositories.
Description
technical field [0001] The invention relates to the new medical application of the cubiying pharmaceutical composition, specifically the application of the cubiying pharmaceutical composition in the preparation of prostate disease medicine, and also relates to the pharmaceutical preparation of the medicine. The invention belongs to the technical field of medicine. Background technique [0002] Prostate disease is caused by the low resistance of the body, bacteria or other pathogens infecting the prostate and rapidly growing and multiplying. Most of them are blood circulation infection or transurethral retrograde infection, which induces prostatitis. Glandular interstitium has mild hyperplastic tissue, the structure is mainly hyperplastic connective tissue and smooth muscle, and there are enlarged glandular sacs, hyperplastic ductal epithelium protruding into the cyst cavity in a papillary shape, forming a mixture of interstitial glandular tissue Sexual nodules, thus forming ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more